Bone Biologics Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 1.61 million compared to USD 1.82 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.156 USD | +0.56% |
|
+1.44% | -74.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.42% | 1.27M | |
+12.53% | 127B | |
+0.97% | 12B | |
-18.47% | 6.88B | |
+56.18% | 6.86B | |
+9.30% | 3.47B | |
-15.71% | 2.54B | |
-18.25% | 1.9B | |
-27.00% | 1.58B | |
-37.52% | 1.43B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021